Bowel Perforation in a Patient with Hepatocellular Carcinoma during Lenvatinib Treatment

We present a case of severe bowel perforation during lenvatinib treatment for advanced hepatocellular carcinoma. Although the Hartmann's procedure was performed, the patient died 48 h after the operation. The histopathological findings suggested that lenvatinib was involved in the etiology of b...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizokami, Ken, Watanabe, Akiko, Yamaguchi, Eriko, Saito, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459524/
https://www.ncbi.nlm.nih.gov/pubmed/36157608
http://dx.doi.org/10.1159/000525569
Descripción
Sumario:We present a case of severe bowel perforation during lenvatinib treatment for advanced hepatocellular carcinoma. Although the Hartmann's procedure was performed, the patient died 48 h after the operation. The histopathological findings suggested that lenvatinib was involved in the etiology of bowel perforation in this case.

Ejemplares similares